Belén Garijo, a prominent Spanish executive, is set to return to Sanofi as its new CEO after a successful five-year tenure at Merck. Known for her powerful presence in the corporate world, particularly in Germany, Garijo has been hailed as 'Spain's most international woman' due to her significant contributions in the global pharmaceutical landscape. Her journey to this high-profile role began in Spain, where she studied medicine and demonstrated leadership skills early on, leading protests during her university days.

At the age of 65, Garijo’s transition to Sanofi comes at a crucial time for the company, which has faced stagnation in the stock market. Her appointment is seen as a strategic move aimed at revitalizing the company's operations and enhancing its competitiveness in the industry. Over the years, her bold leadership style and commitment to innovation have inspired many, and her return to a leading role in a major pharmaceutical firm highlights her enduring influence and expertise in navigating complex market dynamics.

Garijo's legacy is not only centered on her professional achievements but also her role as a trailblazer for women in business. Her daughter, Irene Mora Garijo, has previously remarked on her mother’s powerful persona and relentless work ethic, which resonate with many aspiring women leaders. As Garijo prepares for this new chapter, her career serves as an inspiration for future generations, showcasing how determination and skill can lead to success on both national and international stages.